Background Making an accurate diagnosis in patients with disorders of consciousness remains challenging. F-18-fluorodeoxyglucose (FDG)-PET has been validated as a diagnostic tool in this population, and allows identifying unresponsive patients with a capacity for consciousness. In parallel, the perturbational complexity index (PCI), a new measure based on the analysis of the electroencephalographic response to transcranial magnetic stimulation, has also been suggested as a tool to distinguish between unconscious and conscious states. The aim of the study was to cross-validate FDG-PET and PCI, and to identify signs of consciousness in otherwise unresponsive patients. Methods We jointly applied the Coma Recovery Scale-Revised, FDG-PET and PCI to assess 24 patients with non-acute disorders of consciousness or locked-in syndrome(13 male; 19-54 years old; 12 traumatic; 9 unresponsive wakefulness syndrome, 11 minimally conscious state; 2 emergence from the minimally conscious state, and 2 locked-in syndrome). Results FDG-PET and PCI provided congruent results in 22 patients, regardless of their behavioural diagnosis. Notably, FDG-PET and PCI revealed preserved metabolic rates and high complexity levels in four patients who were behaviourally unresponsive. Conclusion We propose that jointly measuring the metabolic activity and the electrophysiological complexity of cortical circuits is a useful complement to the diagnosis and stratification of patients with disorders of consciousness.

Measures of metabolism and complexity in the brain of patients with disorders of consciousness / O. Bodart, O. Gosseries, S. Wannez, A. Thibaut, J. Annen, M. Boly, M. Rosanova, A.G. Casali, S. Casarotto, G. Tononi, M. Massimini, S. Laureys. - In: NEUROIMAGE. CLINICAL. - ISSN 2213-1582. - 14(2017), pp. 354-362. [10.1016/j.nicl.2017.02.002]

Measures of metabolism and complexity in the brain of patients with disorders of consciousness

M. Rosanova;S. Casarotto;M. Massimini
Penultimo
;
2017

Abstract

Background Making an accurate diagnosis in patients with disorders of consciousness remains challenging. F-18-fluorodeoxyglucose (FDG)-PET has been validated as a diagnostic tool in this population, and allows identifying unresponsive patients with a capacity for consciousness. In parallel, the perturbational complexity index (PCI), a new measure based on the analysis of the electroencephalographic response to transcranial magnetic stimulation, has also been suggested as a tool to distinguish between unconscious and conscious states. The aim of the study was to cross-validate FDG-PET and PCI, and to identify signs of consciousness in otherwise unresponsive patients. Methods We jointly applied the Coma Recovery Scale-Revised, FDG-PET and PCI to assess 24 patients with non-acute disorders of consciousness or locked-in syndrome(13 male; 19-54 years old; 12 traumatic; 9 unresponsive wakefulness syndrome, 11 minimally conscious state; 2 emergence from the minimally conscious state, and 2 locked-in syndrome). Results FDG-PET and PCI provided congruent results in 22 patients, regardless of their behavioural diagnosis. Notably, FDG-PET and PCI revealed preserved metabolic rates and high complexity levels in four patients who were behaviourally unresponsive. Conclusion We propose that jointly measuring the metabolic activity and the electrophysiological complexity of cortical circuits is a useful complement to the diagnosis and stratification of patients with disorders of consciousness.
brain injury; CRS-R, coma recovery scale-revised; DOC, disorders of consciousness; disorders of consciousness; EMCS, emergence from the minimally conscious state; electroencephalography; FDG, 18F-fluorodeoxyglucose; LIS, locked-in syndrome; MCS*, non-behavioural minimally conscious state; MCS, minimally conscious state; PCI, perturbational complexity index; Positron emission tomography; SPM, statistical parametric mapping; TMS–EEG, transcranial magnetic stimulation coupled with high-density EEG; transcranial magnetic stimulation; UWS, unresponsive wakefulness syndrome; unresponsive wakefulness syndrome minimally conscious state; fMRI, functional MRI
Settore BIO/09 - Fisiologia
2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
Bodart_Neuroimage_Clinical2017.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.79 MB
Formato Adobe PDF
1.79 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/499405
Citazioni
  • ???jsp.display-item.citation.pmc??? 48
  • Scopus 96
  • ???jsp.display-item.citation.isi??? 90
social impact